Hypercholesterolaemia

Metabolic·MeSH: Hypercholesterolemia

11 drugs in development·3 companies·5 clinical trials

Drug Pipeline by Phase

Phase 3(7)

Drug	Company
laroprovstat	ASTRAZENECA PLC (AZN)
laroprovstat/rosuvastatin 1	ASTRAZENECA PLC (AZN)
laroprovstat/rosuvastatin 2	ASTRAZENECA PLC (AZN)
rosuvastatin 1	ASTRAZENECA PLC (AZN)
rosuvastatin 2	ASTRAZENECA PLC (AZN)
rosuvastatin 3	ASTRAZENECA PLC (AZN)
rosuvastatin 4	ASTRAZENECA PLC (AZN)

Phase 2(3)

Drug	Company
inclisiran	Novartis AG (NVS)
qcz484	NOVARTIS AG (NVSEF)
qcz484	Novartis AG (NVS)

Phase 4(1)

Drug	Company
Inclisiran	Novartis AG (NVS)

Compare drugs

laroprovstat vs laroprovstat/rosuvastatin 1 laroprovstat vs laroprovstat/rosuvastatin 2 laroprovstat vs rosuvastatin 1

Frequently asked questions

How many drugs are in development for Hypercholesterolaemia?

BioSniper tracks 11 drugs in development for Hypercholesterolaemia across 3 companies.

How many clinical trials target Hypercholesterolaemia?

There are 5 clinical trials targeting Hypercholesterolaemia tracked by BioSniper.

Deep-dive into Hypercholesterolaemia

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Hypercholesterolaemia — Drugs in Development & Clinical Trials | BioSniper